Eyepoint Pharmaceuticals Inc (EYPT) — Free Cash Flow Generation Index
Eyepoint Pharmaceuticals Inc (EYPT) has a Free Cash Flow Generation Index of 0.99x as of June 2023. Free cash flow of $56.63 Million represents 1% of operating cash flow ($57.02 Million). Explore capital reinvestment ratio of Eyepoint Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Eyepoint Pharmaceuticals Inc Free Cash Flow Generation Index (2010–2023)
Historical FCF Generation Index trend for Eyepoint Pharmaceuticals Inc across 3 annual periods. For the full cash flow conversion analysis, see how efficiently does Eyepoint Pharmaceuticals Inc generate cash.
Annual Free Cash Flow Generation for Eyepoint Pharmaceuticals Inc (2010–2023)
Year-by-year Free Cash Flow Generation Index for Eyepoint Pharmaceuticals Inc. Check Eyepoint Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.86x | $-1.61 Million | $1.88 Million | $3.48 Million | ▼ -187.1% |
| 2015 | 0.98x | $10.14 Million | $10.30 Million | $161.00K | ▼ -1.4% |
| 2010 | 1.00x | $9.88 Million | $9.90 Million | $15.00K | — |